Increased therapeutic potential of an experimental anti-mitotic inhibitor SB715992 by genistein in PC-3 human prostate cancer cell line
2006

Combining Genistein with SB715992 Enhances Anti-Cancer Effects in Prostate Cancer Cells

publication Evidence: moderate

Author Information

Author(s): David A. Davis, Sarah H. Sarkar, Maha Hussain, Yiwei Li, Fazlul H. Sarkar

Primary Institution: Wayne State University School of Medicine

Hypothesis

Can the anti-mitotic inhibitor SB715992's effects on prostate cancer cells be enhanced by the addition of genistein?

Conclusion

SB715992 is a potent anti-tumor agent whose therapeutic effects could be enhanced by genistein.

Supporting Evidence

  • SB715992 inhibited cell proliferation and induced apoptosis in PC-3 cells.
  • Combination treatment with SB715992 and genistein caused significantly greater cell growth inhibition compared to either agent alone.
  • Genistein increased the growth inhibitory effects of SB715992 on PC-3 cells.

Takeaway

This study found that a new cancer drug, SB715992, works better when combined with a natural substance called genistein, which comes from soy.

Methodology

PC-3 cells were treated with SB715992 and genistein, followed by assays for cell proliferation, apoptosis, and gene expression analysis.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1471-2407-6-22

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication